CATALOGO DEI PRODOTTI DELLA RICERCA

CASTAGNA, Annalisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.011
NA - Nord America 5.870
AS - Asia 3.690
SA - Sud America 558
AF - Africa 83
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.772
RU - Federazione Russa 2.661
SG - Singapore 1.470
CN - Cina 1.214
GB - Regno Unito 1.057
DE - Germania 495
BR - Brasile 451
IT - Italia 354
SE - Svezia 352
HK - Hong Kong 313
FR - Francia 285
VN - Vietnam 264
IE - Irlanda 259
FI - Finlandia 248
KR - Corea 98
JP - Giappone 88
UA - Ucraina 70
AR - Argentina 55
CA - Canada 55
IN - India 51
BE - Belgio 45
NL - Olanda 39
TR - Turchia 35
ID - Indonesia 34
PL - Polonia 31
ZA - Sudafrica 29
MX - Messico 26
BD - Bangladesh 18
ES - Italia 18
AT - Austria 15
LT - Lituania 14
CL - Cile 12
IQ - Iraq 12
VE - Venezuela 12
RO - Romania 11
AU - Australia 10
IL - Israele 10
UZ - Uzbekistan 10
CH - Svizzera 9
EG - Egitto 9
IR - Iran 8
PK - Pakistan 8
CO - Colombia 7
DZ - Algeria 7
KE - Kenya 7
SA - Arabia Saudita 7
BJ - Benin 6
EC - Ecuador 6
TG - Togo 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
GR - Grecia 5
MA - Marocco 5
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
EE - Estonia 4
JM - Giamaica 4
KG - Kirghizistan 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
PT - Portogallo 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
DK - Danimarca 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
JO - Giordania 2
LK - Sri Lanka 2
NO - Norvegia 2
RS - Serbia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
IS - Islanda 1
Totale 16.210
Salva come PNG Salva come JPEG
Città #
Moscow 921
Southend 856
Dallas 790
Singapore 745
Chandler 741
Jacksonville 506
Ashburn 475
Ann Arbor 359
Hong Kong 307
Woodbridge 307
Dublin 259
Houston 218
Beijing 210
New York 191
Verona 133
Wilmington 119
Munich 117
Los Angeles 108
The Dalles 107
Lawrence 102
Princeton 102
Tokyo 86
Jinan 84
Ho Chi Minh City 83
Nanjing 77
Boardman 76
Shenyang 70
Helsinki 65
Hanoi 50
Redondo Beach 49
Buffalo 46
Brussels 45
São Paulo 44
Santa Clara 43
Hebei 42
Columbus 41
Turku 38
Tianjin 37
Redmond 35
Sindelfingen 34
Lancaster 33
Zhengzhou 32
Changsha 31
Milan 31
Haikou 29
Nanchang 29
Seattle 26
Jiaxing 25
Warsaw 24
Hangzhou 23
London 23
Rio de Janeiro 23
Brooklyn 21
Falkenstein 21
Jakarta 21
Johannesburg 21
Seoul 21
Denver 20
Dong Ket 20
Guangzhou 20
Taiyuan 20
Montreal 19
Orem 19
Padova 19
Ningbo 18
Toronto 18
Phoenix 17
Taizhou 17
Poplar 16
Atlanta 15
Chicago 15
Falls Church 15
Norwalk 15
Nürnberg 14
Council Bluffs 13
Fuzhou 13
Haiphong 13
San Francisco 13
Shanghai 13
Stockholm 13
Vienna 13
Ankara 12
Chennai 12
Fairfield 12
Washington 12
Amsterdam 11
Boydton 11
Dearborn 11
Mexico City 11
Redwood City 11
Bologna 10
Hải Dương 10
Manchester 10
Mumbai 10
Nuremberg 10
Bexley 9
Düsseldorf 9
Frankfurt am Main 9
Lanzhou 9
Tashkent 9
Totale 9.738
Salva come PNG Salva come JPEG
Nome #
Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma 319
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 299
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 220
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 197
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 193
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 192
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 189
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 186
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 182
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 181
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 176
Immunoaffinity reactors for prion protein qualitative analysis 176
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 176
miRNAs purification and analysis from urinary exosomes. 176
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 176
Identification of new BMP6 pro-peptide mutations in patients with iron overload 175
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 175
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 173
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 171
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 170
Altered paraoxonase expression in patients with genetic haemochromatosis. 169
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 168
The proteome: anno Domini 2002 167
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 166
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 165
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 164
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 161
"Exploring the hidden human urinary proteome via ligand library beads" 161
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 161
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 160
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 156
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 156
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 154
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 153
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 152
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 152
“Proteomics approaches for studying chemoresistance in cancer” 151
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 150
"Prefractionation of urinary proteins" 149
Monocyte/macrophage proteomics: recent findings and biomedical applications. 148
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 146
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 146
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 146
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 146
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 145
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 145
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 145
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 145
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 144
Murine macrophages response to iron 144
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 144
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 143
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 143
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 142
Iron metabolism in Murine Macrophages: a proteomic insight. 140
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 138
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 136
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 134
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 134
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 134
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 133
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 132
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 130
null 129
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 129
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 129
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 129
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 127
Optimizing the purification and analysis of miRNAs from urinary exosomes. 126
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 126
Modern iron replacement therapy: clinical and pathophysiological insights 125
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 121
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 121
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 120
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 120
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 118
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 117
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 115
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 115
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 114
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 114
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 114
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 114
Reduced serum hepcidin levels in patients with chronic hepatitis C 113
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 112
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 111
Beta-elimination: an unexpected artefact in proteome analysis. 111
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 110
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 109
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 108
Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals 107
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 107
Reducing protein concentration range of biological samples using solid-phase ligand libraries 106
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 104
Hormone-Dependent Changes in Female Urinary Proteome 103
Recent trends in proteome analysis. 99
Urinary extracellular vesicle mRNA analysis of sodium chloride cotransporter in hypertensive patients under different conditions 97
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 96
Prefractionation techniques in proteome analysis. 95
Treatment options for anemia in the elderly 95
Totale 14.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.269
article - articoli 42.092
book - libri 0
conference - conferenze 10.894
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.283
Totale 108.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021376 0 0 0 0 0 89 25 53 45 25 91 48
2021/2022812 62 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/20252.503 125 183 123 427 97 94 128 86 344 160 209 527
2025/20266.206 562 407 887 1.525 2.285 540 0 0 0 0 0 0
Totale 16.384